Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca D Dodd

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2020
Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle-based Chemotherapy in <i>Pten</i>-deleted Mouse Models of SarcomaRebecca D Dodd, Amanda Scherer, Wesley Huang, et al.
Science Advances|August 13, 2025
Somatic CRISPR tumorigenesis and multiomic analysis reveal a pentose phosphate pathway disruption vulnerability in MPNSTsGavin R McGivney, Qierra R Brockman, Nicholas Borcherding, et al.
Cell Reports|November 19, 2013
Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cellsJordan M Blum, Leonor Añó, Zhizhong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2020
RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 InhibitorsJordan L Kohlmeyer, Courtney A Kaemmer, Casey Pulliam, et al.
Nature Communications|July 11, 2017
Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcomaJianguo Huang, Mark Chen, Melodi Javid Whitley, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 2, 2023
Low-Cost, High-Pressure-Synthesized Oxygen-Entrapping Materials to Improve Treatment of Solid TumorsJianling Bi, Emily Witt, Vanessa A Voltarelli, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitorsCaroline E Wheeler, Samuel S Coleman, Rebecca Hoyd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2023
CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor RegressionJordan L Kohlmeyer, Joshua J Lingo, Courtney A Kaemmer, et al.
Cancer Research Communications|July 17, 2024
The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint InhibitorsCaroline E Dravillas, Samuel S Coleman, Rebecca Hoyd, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
A bioinformatics tool for identifying intratumoral microbes from the ORIEN datasetCankun Wang, Anjun Ma, Megan E McNutt, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2020
Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle-based Chemotherapy in <i>Pten</i>-deleted Mouse Models of SarcomaRebecca D Dodd, Amanda Scherer, Wesley Huang, et al.
Science Advances|August 13, 2025
Somatic CRISPR tumorigenesis and multiomic analysis reveal a pentose phosphate pathway disruption vulnerability in MPNSTsGavin R McGivney, Qierra R Brockman, Nicholas Borcherding, et al.
Cell Reports|November 19, 2013
Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cellsJordan M Blum, Leonor Añó, Zhizhong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2020
RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 InhibitorsJordan L Kohlmeyer, Courtney A Kaemmer, Casey Pulliam, et al.
Nature Communications|July 11, 2017
Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcomaJianguo Huang, Mark Chen, Melodi Javid Whitley, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 2, 2023
Low-Cost, High-Pressure-Synthesized Oxygen-Entrapping Materials to Improve Treatment of Solid TumorsJianling Bi, Emily Witt, Vanessa A Voltarelli, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitorsCaroline E Wheeler, Samuel S Coleman, Rebecca Hoyd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2023
CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor RegressionJordan L Kohlmeyer, Joshua J Lingo, Courtney A Kaemmer, et al.
Cancer Research Communications|July 17, 2024
The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint InhibitorsCaroline E Dravillas, Samuel S Coleman, Rebecca Hoyd, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
A bioinformatics tool for identifying intratumoral microbes from the ORIEN datasetCankun Wang, Anjun Ma, Megan E McNutt, et al.
Pageof 6